Trimethoprim-sulphamethoxazole in the treatment of infections caused by erythromycin-resistant group A streptococci.
Karabiber
N
N
D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D004917:Erythromycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination